Cancer-Related Worry in Canadian Thyroid Cancer Survivors

Author:

Bresner Lauren1,Banach Rita2,Rodin Gary3,Thabane Lehana4,Ezzat Shereen5,Sawka Anna M.5

Affiliation:

1. Division of Endocrinology (L.B.), Department of Medicine, Toronto General Hospital, Toronto, ON M5G 2C4, Canada;

2. Thyroid Cancer Canada (R.B.), Toronto, ON M5N 3A8, Canada;

3. Department of Psychosocial Oncology (G.R.), Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada;

4. Department of Clinical Epidemiology and Biostatistics (L.T.), St. Joseph's Healthcare and McMaster University, Hamilton, ON L8N 4A6, Canada;

5. Division of Endocrinology (S.E., A.M.S.), University Health Network and University of Toronto, Toronto, ON M5G 2N2, Canada

Abstract

Context: Little is known about cancer-related worry in thyroid cancer survivors. Objectives: We quantified cancer-related worry in Canadian thyroid cancer survivors and explored associated factors. Design, Setting, and Participants: We performed a cross-sectional, self-administered, written survey of thyroid cancer survivor members of the Thyroid Cancer Canada support group. Independent factors associated with cancer-related worry were identified using a multivariable linear regression analysis. Main Outcome Measure: We used the Assessment of Survivor Concerns (ASC) questionnaire, which includes questions on worry about diagnostic tests, second primary malignancy, recurrence, dying, health, and children's health. Results: The response rate for eligible members was 60.1% (941 of 1567). Most respondents were women (89.0%; 837 of 940), and the age was < 50 years in 54.0% of participants (508 of 941). Thyroid cancer was diagnosed within ≤ 5 years in 66.1% of participants (622 of 940). The mean overall ASC score was 15.34 (SD, 4.7) (on a scale from 6 [least worry] to 24 [most worry]). Factors associated with increased ASC score included: younger age (P < .001), current suspected or proven recurrent/persistent disease (ie, current proven active disease or abnormal diagnostic tests) (P < .001), partnered marital status (P = .021), having children (P = .029), and ≤5 years since thyroid cancer diagnosis (P = .017). Conclusions: In a population of Canadian thyroid cancer survivors, cancer-related worry was greatest in younger survivors and those with either confirmed or suspected disease activity. Family status and time since thyroid cancer diagnosis were also associated with increased worry. More research is needed to confirm these findings and to develop effective preventative and supportive strategies for those at risk.

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference39 articles.

1. Canadian Cancer Society, Statistics Canada, Public Health Agency of Canada, and Provincial/Territorial Cancer Registries. Canadian Cancer Statistics. 2014. http://www.cancer.ca/∼/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2014-EN.pdf. Accessed October 13, 2014

2. Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991–2006;Guay;Thyroid,2014

3. Cancer in Canada fact sheet series #1 - thyroid cancer in Canada;Shaw;Chronic Dis Inj Can,2014

4. National Cancer Institute. Surveillance Epidemiology and End Results. 2013 SEER Stat Fact Sheets: Thyroid Cancer. http://seer.cancer.gov/statfacts/html/thyro.html. Accessed July 18, 2014

5. Current thyroid cancer trends in the United States;Davies;JAMA Otolaryngol Head Neck Surg,2014

Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3